1. Home
  2. TMDX vs MCY Comparison

TMDX vs MCY Comparison

Compare TMDX & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • MCY
  • Stock Information
  • Founded
  • TMDX 1998
  • MCY 1961
  • Country
  • TMDX United States
  • MCY United States
  • Employees
  • TMDX N/A
  • MCY N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MCY Property-Casualty Insurers
  • Sector
  • TMDX Health Care
  • MCY Finance
  • Exchange
  • TMDX Nasdaq
  • MCY Nasdaq
  • Market Cap
  • TMDX 3.9B
  • MCY 4.3B
  • IPO Year
  • TMDX 2019
  • MCY N/A
  • Fundamental
  • Price
  • TMDX $107.79
  • MCY $77.87
  • Analyst Decision
  • TMDX Buy
  • MCY Strong Buy
  • Analyst Count
  • TMDX 10
  • MCY 1
  • Target Price
  • TMDX $122.11
  • MCY $90.00
  • AVG Volume (30 Days)
  • TMDX 934.4K
  • MCY 218.8K
  • Earning Date
  • TMDX 10-27-2025
  • MCY 10-28-2025
  • Dividend Yield
  • TMDX N/A
  • MCY 1.63%
  • EPS Growth
  • TMDX 2163.11
  • MCY 22.11
  • EPS
  • TMDX 2.02
  • MCY 7.04
  • Revenue
  • TMDX $531,292,000.00
  • MCY $5,768,316,000.00
  • Revenue This Year
  • TMDX $38.86
  • MCY $7.13
  • Revenue Next Year
  • TMDX $20.79
  • MCY $7.60
  • P/E Ratio
  • TMDX $53.44
  • MCY $11.04
  • Revenue Growth
  • TMDX 48.09
  • MCY 14.93
  • 52 Week Low
  • TMDX $55.00
  • MCY $44.19
  • 52 Week High
  • TMDX $169.29
  • MCY $80.72
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 39.83
  • MCY 63.96
  • Support Level
  • TMDX $101.00
  • MCY $76.01
  • Resistance Level
  • TMDX $117.96
  • MCY $78.96
  • Average True Range (ATR)
  • TMDX 5.07
  • MCY 1.57
  • MACD
  • TMDX -1.15
  • MCY -0.15
  • Stochastic Oscillator
  • TMDX 31.08
  • MCY 74.78

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

Share on Social Networks: